Literature DB >> 23046381

Understanding cytokine and growth factor receptor activation mechanisms.

Mariya Atanasova1, Adrian Whitty.   

Abstract

Our understanding of the detailed mechanism of action of cytokine and growth factor receptors - and particularly our quantitative understanding of the link between structure, mechanism and function - lags significantly behind our knowledge of comparable functional protein classes such as enzymes, G protein-coupled receptors, and ion channels. In particular, it remains controversial whether such receptors are activated by a mechanism of ligand-induced oligomerization, versus a mechanism in which the ligand binds to a pre-associated receptor dimer or oligomer that becomes activated through subsequent conformational rearrangement. A major limitation to progress has been the relative paucity of methods for performing quantitative mechanistic experiments on unmodified receptors expressed at endogenous levels on live cells. In this article, we review the current state of knowledge on the activation mechanisms of cytokine and growth factor receptors, critically evaluate the evidence for and against the different proposed mechanisms, and highlight other key questions that remain unanswered. New approaches and techniques have led to rapid recent progress in this area, and the field is poised for major advances in the coming years which promise to revolutionize our understanding of this large and biologically and medically important class of receptors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046381      PMCID: PMC3537265          DOI: 10.3109/10409238.2012.729561

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  218 in total

1.  Rational design of potent antagonists to the human growth hormone receptor.

Authors:  G Fuh; B C Cunningham; R Fukunaga; S Nagata; D V Goeddel; J A Wells
Journal:  Science       Date:  1992-06-19       Impact factor: 47.728

2.  Distribution of resting and ligand-bound ErbB1 and ErbB2 receptor tyrosine kinases in living cells using number and brightness analysis.

Authors:  Peter Nagy; Jeroen Claus; Thomas M Jovin; Donna J Arndt-Jovin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-02       Impact factor: 11.205

3.  Structures of the extracellular domain of the type I tumor necrosis factor receptor.

Authors:  J H Naismith; T Q Devine; T Kohno; S R Sprang
Journal:  Structure       Date:  1996-11-15       Impact factor: 5.006

4.  Oligomerization of the EGF receptor investigated by live cell fluorescence intensity distribution analysis.

Authors:  Saveez Saffarian; Yu Li; Elliot L Elson; Linda J Pike
Journal:  Biophys J       Date:  2007-05-11       Impact factor: 4.033

5.  Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies.

Authors:  Christine Kowalczyk; Nathalie Dunkel; Laure Willen; Margret L Casal; Elizabeth A Mauldin; Olivier Gaide; Aubry Tardivel; Giovanna Badic; Anne-Lise Etter; Manuel Favre; Douglas M Jefferson; Denis J Headon; Stéphane Demotz; Pascal Schneider
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

6.  Seeing double: crystal structures of the type I TNF receptor.

Authors:  J H Naismith; B J Brandhuber; T Q Devine; S R Sprang
Journal:  J Mol Recognit       Date:  1996 Mar-Apr       Impact factor: 2.137

7.  Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.

Authors:  Rivka Adar; Efrat Monsonego-Ornan; Pe'er David; Avner Yayon
Journal:  J Bone Miner Res       Date:  2002-05       Impact factor: 6.741

Review 8.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

9.  Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6.

Authors:  Sowmya Viswanathan; Tania Benatar; Stefan Rose-John; Doug A Lauffenburger; Peter W Zandstra
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

Review 10.  Janus kinases in immune cell signaling.

Authors:  Kamran Ghoreschi; Arian Laurence; John J O'Shea
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more
  31 in total

Review 1.  Aberrant expression of genes and proteins in pterygium and their implications in the pathogenesis.

Authors:  Qing-Yang Feng; Zi-Xuan Hu; Xi-Ling Song; Hong-Wei Pan
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

Review 2.  Immune signalling by supramolecular assemblies.

Authors:  Santosh Kumar; Shweta Jain
Journal:  Immunology       Date:  2018-09-24       Impact factor: 7.397

3.  Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations.

Authors:  Stephan Wilmes; Maximillian Hafer; Joni Vuorio; Julie A Tucker; Hauke Winkelmann; Sara Löchte; Tess A Stanly; Katiuska D Pulgar Prieto; Chetan Poojari; Vivek Sharma; Christian P Richter; Rainer Kurre; Stevan R Hubbard; K Christopher Garcia; Ignacio Moraga; Ilpo Vattulainen; Ian S Hitchcock; Jacob Piehler
Journal:  Science       Date:  2020-02-07       Impact factor: 47.728

4.  Glycopolymer induction of mouse sperm acrosomal exocytosis shows highly cooperative self-antagonism.

Authors:  Maria T Rodolis; He Huang; Nicole S Sampson
Journal:  Biochem Biophys Res Commun       Date:  2016-05-02       Impact factor: 3.575

5.  A Residue Quartet in the Extracellular Domain of the Prolactin Receptor Selectively Controls Mitogen-activated Protein Kinase Signaling.

Authors:  Chi Zhang; Mads Nygaard; Gitte W Haxholm; Florence Boutillon; Marie Bernadet; Sylviane Hoos; Patrick England; Isabelle Broutin; Birthe B Kragelund; Vincent Goffin
Journal:  J Biol Chem       Date:  2015-03-17       Impact factor: 5.157

6.  Decoupling the Functional Pleiotropy of Stem Cell Factor by Tuning c-Kit Signaling.

Authors:  Chia Chi M Ho; Akanksha Chhabra; Philipp Starkl; Peter-John Schnorr; Stephan Wilmes; Ignacio Moraga; Hye-Sook Kwon; Nicolas Gaudenzio; Riccardo Sibilano; Tom S Wehrman; Milica Gakovic; Jonathan T Sockolosky; Matthew R Tiffany; Aaron M Ring; Jacob Piehler; Irving L Weissman; Stephen J Galli; Judith A Shizuru; K Christopher Garcia
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

7.  Structural insight into the transmembrane domain and the juxtamembrane region of the erythropoietin receptor in micelles.

Authors:  Qingxin Li; Ying Lei Wong; Qiwei Huang; CongBao Kang
Journal:  Biophys J       Date:  2014-11-18       Impact factor: 4.033

8.  Regulation of Transmembrane Signaling by Phase Separation.

Authors:  Lindsay B Case; Jonathon A Ditlev; Michael K Rosen
Journal:  Annu Rev Biophys       Date:  2019-04-05       Impact factor: 12.981

9.  CXCR5 overexpression in HL-60 cells enhances chemotaxis toward CXCL13 without anticipated interaction partners or enhanced MAPK signaling.

Authors:  Robert J MacDonald; Andrew Yen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-10-01       Impact factor: 2.416

10.  Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain.

Authors:  Nanaocha Sharma; Geeta Longjam; Gideon Schreiber
Journal:  J Biol Chem       Date:  2015-12-17       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.